Shiakolas, Andrea R.
Kramer, Kevin J. http://orcid.org/0000-0001-8451-9018
Johnson, Nicole V. http://orcid.org/0000-0003-4351-125X
Wall, Steven C.
Suryadevara, Naveenchandra http://orcid.org/0000-0003-2571-1290
Wrapp, Daniel http://orcid.org/0000-0002-0538-9647
Periasamy, Sivakumar http://orcid.org/0000-0002-7038-5140
Pilewski, Kelsey A. http://orcid.org/0000-0003-0916-4098
Raju, Nagarajan
Nargi, Rachel
Sutton, Rachel E.
Walker, Lauren M.
Setliff, Ian http://orcid.org/0000-0003-4726-6132
Crowe, James E. Jr http://orcid.org/0000-0002-0049-1079
Bukreyev, Alexander http://orcid.org/0000-0002-0342-4824
Carnahan, Robert H. http://orcid.org/0000-0001-5230-1532
McLellan, Jason S. http://orcid.org/0000-0003-3991-542X
Georgiev, Ivelin S. http://orcid.org/0000-0002-6312-7696
Article History
Received: 2 June 2021
Accepted: 24 January 2022
First Online: 3 March 2022
Competing interests
: A.R.S. and I.S.G. are cofounders of AbSeek Bio. I.S.G., A.R.S. and K.J.K. are listed as inventors on antibodies described herein. I.S.G., A.R.S. and I.S. are listed as inventors on patent applications for the LIBRA-seq technology. J.E.C. has served as a consultant for Luna Biologics, is a member of the Scientific Advisory Board Meissa Vaccines and is Founder of IDBiologics. The Crowe laboratory has received funding support in sponsored research agreements from AstraZeneca, IDBiologics and Takeda. The Georgiev laboratory at VUMC has received unrelated funding from Takeda Pharmaceuticals. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.